COH Agreements (Details Textual) - USD ($) |
1 Months Ended | 3 Months Ended | 7 Months Ended | 9 Months Ended | |
|---|---|---|---|---|---|
Mar. 17, 2015 |
Sep. 30, 2016 |
Sep. 30, 2015 |
Sep. 30, 2015 |
Sep. 30, 2016 |
|
| Research and Development Expense | $ 500,000 | $ 500,000 | $ 1,000,000 | $ 1,500,000 | |
| City Of Hope [Member] | |||||
| Payment Of Upfront Fees | $ 2,000,000 | ||||
| Stock Issued During Period, Shares, Other | 1,000,000 | ||||
| Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners | 10.00% | ||||
| Revenue Recognition Milestone Method Payments Due | $ 2,000,000 | ||||
| Royalty Guarantees, Commitments, Amount | $ 1,000,000 | ||||
| Marketability Percentage Of Invested Capital | 44.80% | ||||
| Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent | 30.00% | ||||
| Share Price | $ 0.147 | ||||
| Stock Issued During Period, Value, Other | $ 147,000 | ||||
| Research And Development Expense, Sponsored Research Payment | 2,000,000 | ||||
| City Of Hope [Member] | Development Milestone [Member] | |||||
| Research And Development Milestone | $ 14,500,000 | ||||
| X | ||||||||||
- Definition Represents the marketability percentage of invested capital. No definition available.
|
| X | ||||||||||
- Definition Payment of Upfront Fees No definition available.
|
| X | ||||||||||
- Definition The amount of research and development expense payable on achieving milestone targets. No definition available.
|
| X | ||||||||||
- Definition The amount of consideration eligible to receive during the period for the milestone or milestones No definition available.
|
| X | ||||||||||
- Definition The amount of consideration eligible to receive during the period for the milestone or milestones. No definition available.
|
| X | ||||||||||
- Definition The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity. No definition available.
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The amount the entity has committed to make for future royalty guarantees. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
| X | ||||||||||
- Definition Purchase price of common stock expressed as a percentage of its fair value. No definition available.
|
| X | ||||||||||
- Definition Number of shares of stock issued attributable to transactions classified as other. No definition available.
|
| X | ||||||||||
- Definition Value of shares of stock issued attributable to transactions classified as other. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|